Delivery Order SPE2DB25D3306-SPE2DB25FUCMD
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,062.52 contract is for the supply of 120 mcg/0.5 ml doses of the Trumenba vaccine, with a performance period ending on May 8, 2025. The award is not set-aside and represents an open competition. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,125.04 for TRUMENBA 120MCG (meningococcal B vaccine) on July 28, 2025, with an ultimate completion date of July 29, 2025. The contract, which was competitively awarded with no set-aside designation, utilizes firm fixed pricing and is being performed at the company's Conshohocken, PA facility. This delivery order falls under the Defense Logistics...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of Trumenba 120 mcg/0.5 ml vaccine in 0.5 ml doses. The firm-fixed-price delivery order has a ceiling value of $2,887.80 and an ultimate completion date of June 14, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRUMENBA 120MCG 10S, a vaccine product. The contract has a ceiling value of $1,062.52 and a period of performance through June 30, 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the provision of 120 mcg/0.5 ml doses of the TRUMENBA vaccine, a total ceiling value of $2,125.04. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML. The contract has a ceiling value of $1,062.52 and is a Firm Fixed Price type contract. The place of performance is Conshohocken, Pennsylvania. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is a Delivery Order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,250.08 Firm Fixed Price contract is for the delivery of TRUMENBA 120MCG 10S, a medical supply product. The contract has an ultimate completion date of August 6, 2025 and was awarded on July 10, 2025. This order is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award, valued at $4,250.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 mcg/0.5 ml Trumenba vaccine, with a performance period extending through May 7, 2025. The contract type is a Delivery Order, with a Firm Fixed Price pricing structure. This award is not associated with a set-aside program and represents an open competition....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRUMENBA 120 MCG/0.5 ML VACCIN 0.5ML, a vaccine product. The contract has a ceiling value of $1,222.33 and runs through March 5, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRUMENBA 120MCG 10S, a pharmaceutical product, with a ceiling value of $2,125.04 and a completion date of July 3, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCMDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Trumenba 120 micrograms/0.5 milliliter vaccine in 0.5 milliliter units, with a ceiling value of $1,749.30 and firm fixed pricing. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The performance location is AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical support vehicle, which enables the company to supply a broad range of vaccines, medications, and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated capability to fulfill federal medical procurement requirements through open competition. The contract supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible pharmaceutical procurement mechanisms, consistent with DLA's strategic approach to maintain multiple contractor relationships for medical supply chain resilience.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/31/25 |